Open

New Onset Type 1 Diabetes Non-Interventional Study

The purpose of this study is to evaluate the distribution of a human leukocyte antigen genotype in adults who were recently diagnosed with type 1 diabetes

Age & Gender

18 years ~ 45 years
Male, Female, Gender Inclusive

Visit Availability

Standard business hours (M-F, 8-5)

Location

North Carolina (Statewide)

What will be asked of you

At the in-person visit, you will be asked to review the consent form with the study staff and then provide information about your type 1 diabetes diagnosis, demographics, medical history, and medications. There will be a single blood draw. The study staff will call you 24 hours after the visit to follow up with you.

Incentives

Information provided upon request

In-person visits:
1

Phone or online visits:
1

Total length of participation:
24 hours

Looking for Specific Volunteers

Able to participate:

you have been diagnosed very recently with type 1 diabetes

Not eligible if:

you are an employee of, or an immediate family member of an employee, of GentiBio or UNC

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Primary Visit Location

UNC Eastowne Medical Office Building
100 Eastowne Dr, Chapel Hill, NC 27514, USA

Additional Study Information

Principal Investigator

Klara Klein
Medicine-Endocrinology

Study Type

Clinical or Medical
Observational

Study Topics

Diabetes

IRB Number

25-0914

ClinicalTrials.gov

NCT06860516

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.